Description
Recombinant monoclonal antibody to Claudin-18.2. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the synthetic antibody CLDN18.2-v.19. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
Target
Claudin-18.2
Target Alias Names
CLDN18.2, 2C6.9-HZ21, HuCLDN18.2-v. 19, CLDN18.2 v. 19
Isotype/Mimetic
IgG2b
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Methods
Naïve display libraries derived from human B cells, or naïve display libraries from animal B cells or Display libraries from synthetic or natural framework sequences
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression